Effects of Aromatase Inhibition in Elderly Men with Low or Borderline-Low Serum Testosterone Levels
The DOI matches its Crossref record; 63 of the 68 references it cites were found in a registry or an index.
Abstract
As men age, serum testosterone levels decrease, a factor that may contribute to some aspects of age-related physiological deterioration. Although androgen replacement has been shown to have beneficial effects in frankly hypogonadal men, its use in elderly men with borderline hypogonadism is controversial. Furthermore, current testosterone replacement methods have important limitations. We investigated the ability of the orally administered aromatase inhibitor, anastrozole, to increase endogenous testosterone production in 37 elderly men (aged 62–74 yr) with screening serum testosterone levels less than 350 ng/dl. Subjects were randomized in a double-blind fashion to the following 12-wk oral regimens: group 1: anastrozole 1 mg daily (n = 12); group 2: anastrozole 1 mg twice weekly (n = 11); and group 3: placebo daily (n = 14). Hormone levels, quality of life (MOS Short-Form Health Survey), sexual function (International Index of Erectile Function), benign prostate hyperplasia severity (American Urological Association Symptom Index Score), prostate-specific antigen, and measures of safety were compared among groups. Mean ± sd bioavailable testosterone increased from 99 ± 31 to 207 ± 65 ng/dl in group 1 and from 115 ± 37 to 178 ± 55 ng/dl in group 2 (P < 0.001 vs. placebo for both groups and P = 0.054 group 1 vs. group 2). Total testosterone levels increased from 343 ± 61 to 572 ± 139 ng/dl in group 1 and from 397 ± 106 to 520 ± 91 ng/dl in group 2 (P < 0.001 vs. placebo for both groups and P = 0.012 group 1 vs. group 2). Serum estradiol levels decreased from 26 ± 8 to 17 ± 6 pg/ml in group 1 and from 27 ± 8 to 17 ± 5 pg/ml in group 2 (P < 0.001 vs. placebo for both groups and P = NS group 1 vs. group 2). Serum LH levels increased from 5.1 ± 4.8 to 7.9 ± 6.5 U/liter and from 4.1 ± 1.6 to 7.2 ± 2.8 U/liter in groups 1 and 2, respectively (P = 0.007 group 1 vs. placebo, P = 0.003 group 2 vs. placebo, and P = NS group 1 vs. group 2). Scores for hematocrit, MOS Short-Form Health Survey, International Index of Erectile Function, and American Urological Association Symptom Index Score did not change. Serum prostate-specific antigen levels increased in group 2 only (1.7 ± 1.0 to 2.2 ± 1.5 ng/ml, P = 0.031, compared with placebo). These data demonstrate that aromatase inhibition increases serum bioavailable and total testosterone levels to the youthful normal range in older men with mild hypogonadism. Serum estradiol levels decrease modestly but remain within the normal male range. The physiological consequences of these changes remain to be determined.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These compounds have been shown to raise testosterone levels in hypogonadal men and are also orally administered (64-66).”
From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [65]
In the citing paper
“Aromatase inhibitors effectively delay epiphysial maturation in boys and improve testosterone levels in adult men”
From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [29]
In the citing paper
“In men third-generation aromatase inhibitors will decrease the mean plasma estradiol/testosterone ratio by 77% [28,29].”
From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [29]
In the citing paper
“Lowering estradiol levels, by administering an aromatase inhibitor, is associated with an increase in levels of LH, follicle-stimulating hormone (FSH) and testosterone [28,29].”
From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [29]
In the citing paper
“Although aromatase inhibition by anastrozole and letrozole is reported to be close to 100%, administration of these inhibitors to men will not suppress plasma estradiol levels completely.”
From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [29]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Self-citationGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Self-citationTestosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1661 · Cited by 922
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Effects of testosterone supplementation in the aging male
Tenover, J. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1092 · Cited by 768
Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757
Research works printed but not linked: 1
- Med Lett Drugs Ther, 42, 49
Cited by
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Epoxide hydrolases: their roles and interactions with lipid metabolism
Newman, J. W., Morisseau, C., & Hammock, B. D. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.10.001 · Cited by 474
Oestrogens and spermatogenesis
Carreau, S., & Hess, R. A. (2010) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0235 · Cited by 307
Traish, A. M., Goldstein, I., & Kim, N. N. (2007) · European Urology · doi:10.1016/j.eururo.2007.02.034 · Cited by 268
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., & Salonen, J. T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0970 · Cited by 230
“Consistent with this hypothesis, the aromatase inhibitor anastrozole has been shown to increase total and bioavailable testosterone levels in elderly men with low testosterone levels (47).”
BackgroundThe role of aromatization in testosterone supplementation: Effects on cognition in older men
Cherrier, M. M., Matsumoto, A. M., Amory, J. K., Ahmed, S., Bremner, W., Peskind, E. R., Raskind, M. A., Johnson, M., & Craft, S. (2005) · Neurology · doi:10.1212/01.wnl.0000149639.25136.ca · Cited by 226
Impact of estrogens in males and androgens in females
Hammes, S. R., & Levin, E. R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125755 · Cited by 225
Androgen Abuse in Athletes: Detection and Consequences
Basaria, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1579 · Cited by 198
“Hence, the reflex rise in endogenous testosterone as a result of estrogen blockade may result in myotrophic effects, although the rise in serum testosterone concentrations is modest (50– 65%) (47, 48).”
BackgroundOf mice and men: the evolving phenotype of aromatase deficiency
Jones, M. E. E., Chin Boon, W., Proietto, J., & Simpson, E. R. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.01.004 · Cited by 193
Endocrinology of the aging male
Araujo, A. B., & Wittert, G. A. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.11.004 · Cited by 182
Khera, M., Adaikan, G., Buvat, J., Carrier, S., El-Meliegy, A., Hatzimouratidis, K., McCullough, A., Morgentaler, A., Torres, L. O., & Salonia, A. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.10.009 · Cited by 177
Hypogonadism and male obesity: Focus on unresolved questions
Grossmann, M. (2018) · Clinical Endocrinology · doi:10.1111/cen.13723 · Cited by 164
Aromatase inhibitors in men: effects and therapeutic options
de Ronde, W., & de Jong, F. H. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-93 · Cited by 155
Burnett-Bowie, S.-A. M., McKay, E. A., Lee, H., & Leder, B. Z. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0739 · Cited by 146
“Aromatase Inhibition and BMD in Older Men J Clin Endocrinol Metab, December 2009, 94(12):4785–4792”
BackgroundSelf-citationLetrozole once a week normalizes serum testosterone in obesity-related male hypogonadism
Loves, S., Ruinemans-Koerts, J., & de Boer, H. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0663 · Cited by 141
Raven, G., de Jong, F. H., Kaufman, J.-M., & de Ronde, W. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0462 · Cited by 134
Testosterone and Benign Prostatic Hyperplasia
Rastrelli, G., Vignozzi, L., Corona, G., & Maggi, M. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.10.006 · Cited by 134
The Relationships between Sex Hormones and Sexual Function in Middle-Aged and Older European Men
O'Connor, D. B., Lee, D. M., Corona, G., Forti, G., Tajar, A., O'Neill, T. W., Pendleton, N., Bartfai, G., Boonen, S., Casanueva, F. F., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2216 · Cited by 124
Obesity in men: The hypogonadal–estrogen receptor relationship and its effect on glucose homeostasis
Cohen, P. G. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2007.05.020 · Cited by 115
The role of estrogen in testis and the male reproductive tract: a review and species comparison
Hess, R. A., & Carnes, K. I. (2004) · Cited by 142
Helo, S., Ellen, J., Mechlin, C., Feustel, P., Grossman, M., Ditkoff, E., & McCullough, A. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12944 · Cited by 102
Detection of the misuse of steroids in doping control
Parr, M. K., & Schänzer, W. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.008 · Cited by 98
Fredericson, M., Kussman, A., Misra, M., Barrack, M. T., De Souza, M. J., Kraus, E., Koltun, K. J., Williams, N. I., Joy, E., & Nattiv, A. (2021) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000948 · Cited by 93
Rochira, V., Zirilli, L., Genazzani, A. D., Balestrieri, A., Aranda, C., Fabre, B., Antunez, P., Diazzi, C., Carani, C., & Maffei, L. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02254 · Cited by 89
The mutual dependence between bone and gonads
Karsenty, G. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0452 · Cited by 89
Burnett‐Bowie, S. M., Roupenian, K. C., Dere, M. E., Lee, H., & Leder, B. Z. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03327.x · Cited by 73
Self-citationComparative Assessment in Young and Elderly Men of the Gonadotropin Response to Aromatase Inhibition
T’Sjoen, G. G., Giagulli, V. A., Delva, H., Crabbe, P., De Bacquer, D., & Kaufman, J.-M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0982 · Cited by 73
Banerjee, B., Nandi, P., Chakraborty, S., Raha, S., Sen, P. C., & Jana, K. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.04.003 · Cited by 73
Alternatives to Testosterone Therapy: A Review
Lo, E. M., Rodriguez, K. M., Pastuszak, A. W., & Khera, M. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.09.004 · Cited by 64
Adverse Events Associated with Testosterone Administration
Weikert, C., Pischon, T., & Weikert, S. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1009326 · Cited by 56
Rochira, V., Zirilli, L., Madeo, B., MAFFEI, L. E., & Carani, C. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.007 · Cited by 50
Assessment of Circulating Hormones in Regulatory Toxicity Studies II. Male Reproductive Hormones
Chapin, R. E., & Creasy, D. M. (2012) · Toxicologic Pathology · doi:10.1177/0192623312443321 · Cited by 53
Effects of a Purported Aromatase and 5 α-Reductase Inhibitor on Hormone Profiles in College-Age Men
Wilborn, C., Taylor, L., Poole, C., Foster, C., Willoughby, D., & Kreider, R. (2010) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.20.6.457 · Cited by 46
An update on male hypogonadism therapy
Surampudi, P., Swerdloff, R. S., & Wang, C. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.913022 · Cited by 45
Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men
Leder, B. Z., & Finkelstein, J. S. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1890-8 · Cited by 44
“The details of subject selection and randomization have been previously described [18].”
BackgroundSelf-citationPharmacological management of late-onset hypogonadism
Rastrelli, G., Maggi, M., & Corona, G. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1445969 · Cited by 44
Colleluori, G., Chen, R., Turin, C. G., Vigevano, F., Qualls, C., Johnson, B., Mediwala, S., Villareal, D. T., & Armamento-Villareal, R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00277 · Cited by 43
Diagnosis and management of testosterone deficiency
Coward, R. M., McBride, J., & Carson, C. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.143317 · Cited by 46
Dougherty, R. H., Rohrer, J. L., Hayden, D., Rubin, S. D., & Leder, B. Z. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02205.x · Cited by 43
Self-citationAromatase inhibitors as add–on treatment for men with epilepsy
Harden, C. L., & MacLusky, N. J. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.1.123 · Cited by 43
Greco, E. A., Pili, M., Bruzziches, R., Corona, G., Spera, G., & Aversa, A. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00264.x · Cited by 45
Cavender, R. K., & Fairall, M. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01513.x · Cited by 41
Testosterone Replacement Therapy in Hypogonadal Men
Wang, C., & Swerdloff, R. S. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.11.005 · Cited by 54
Lauro, L. D., Pizzuti, L., Barba, M., Sergi, D., Sperduti, I., Mottolese, M., Amoreo, C. A., Belli, F., Vici, P., Speirs, V., et al. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0147-z · Cited by 40
Late‐onset hypogonadism and lifestyle‐related metabolic disorders
Braga, P. C., Pereira, S., Ribeiro, J. C., Sousa, M., Monteiro, M. P., Oliveira, P. F., & Alves, M. G. (2020) · Andrology · doi:10.1111/andr.12765 · Cited by 46
Age Related Testosterone Depletion in Patients With Erectile Dysfunction
El‐Sakka, A. I., & Hassoba, H. M. (2006) · The Journal of Urology · doi:10.1016/j.juro.2006.08.005 · Cited by 39
Metabolic syndrome and sexual dysfunction
Chughtai, B. I., Lee, R. K., Te, A. E., & Kaplan, S. A. (2011) · Current Opinion in Urology · doi:10.1097/mou.0b013e32834b8681 · Cited by 42
El‐Sakka, A. I. (2013) · Asian Journal of Andrology · doi:10.1038/aja.2013.20 · Cited by 36
Non-testosterone management of male hypogonadism: an examination of the existing literature
Krzastek, S. C., & Smith, R. P. (2020) · Translational Andrology and Urology · doi:10.21037/tau.2019.11.16 · Cited by 33
“These compounds have been shown to raise testosterone levels in hypogonadal men and are also orally administered (64-66).”
BackgroundLapauw, B., T'Sjoen, G., Mahmoud, A., Kaufman, J. M., & Ruige, J. B. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0881 · Cited by 33
Current and future testosterone delivery systems for treatment of the hypogonadal male
Pfeil, E., & Dobs, A. S. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.4.471 · Cited by 30
Khodamoradi, K., Khosravizadeh, Z., Parmar, M., Kuchakulla, M., Ramasamy, R., & Arora, H. (2020) · F&S Reviews · doi:10.1016/j.xfnr.2020.11.001 · Cited by 39
Wu, C. L., & Kovac, J. R. (2016) · Current Urology Reports · doi:10.1007/s11934-016-0629-8 · Cited by 36
Systematic review of hormone replacement therapy in the infertile man
Meliegy, A. E., Motawi, A. T., & Salam, M. A. A. E. (2018) · Arab Journal of Urology · doi:10.1016/j.aju.2017.11.011 · Cited by 29
Horowitz, R. I., & Freeman, P. R. (2018) · Healthcare · doi:10.3390/healthcare6040129 · Cited by 34
Clinical Use of Aromatase Inhibitors in Adult Males
Tan, R., Guay, A. T., & Hellstrom, W. J. G. (2014) · Sexual Medicine Reviews · doi:10.1002/smrj.23 · Cited by 33
Therapeutic uses of aromatase inhibitors in men
de Ronde, W. (2007) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328121aad2 · Cited by 26
Of Mice and Men: The Many Guises of Estrogens
Simpson, E. R., & Jones, M. E. E. (2007) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2006_016 · Cited by 26
Willoughby, D. S., Wilborn, C., Taylor, L. W., & Campbell, W. S. (2007) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.17.1.92 · Cited by 27
Bunck, M. C. M., Toorians, A. W. F. T., Lips, P. T. A. M., & Gooren, L. J. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02126 · Cited by 27
Efficacy of Non-Testosterone-Based Treatment in Hypogonadal Men: A Review.
Raheem, O. A., Chen, T., Akula, K. P., Greenberg, J., Le, T. V., Chernobylsky, D., Sikka, S. C., & Walsh, T. J. (2021) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2020.08.003 · Cited by 22
Male hypogonadism: therapeutic choices and pharmacological management
Vignera, S. L., Izzo, G., Emerenziani, G. P., Cannarella, R., Condorelli, R. A., Calogero, A. E., & Aversa, A. (2020) · Minerva Endocrinology · doi:10.23736/s0391-1977.20.03195-8 · Cited by 24
Leydig cell aging: Molecular mechanisms and treatments
Papadopoulos, V., & Zirkin, B. R. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.023 · Cited by 28
Testosterone replacement in the infertile man
Majzoub, A. A., & Sabanegh, E. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.08.03 · Cited by 26
The latest options and future agents for treating male hypogonadism
Edelstein, D. L., Sivanandy, M. S., Shahani, S., & Basaria, S. S. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.17.2991 · Cited by 25
Jones, T. H., Dobs, A. S., Randeva, H. S., Moore, W., & Parkin, J. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad099 · Cited by 27
Relevance of oestradiol-testosterone balance in erectile dysfunction patients' prognosis.
Srilatha, B., Adaikan, P. G., & Chong, Y. S. (2007) · PubMed · Cited by 23
Androgen receptor and antiandrogen therapy in male breast cancer
Lauro, L. D., Barba, M., Pizzuti, L., Vici, P., Sergi, D., Benedetto, A. D., Mottolese, M., Speirs, V., Santini, D., Maria, R. D., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.040 · Cited by 22
Maugeri‐Saccà, M., Barba, M., Vici, P., Pizzuti, L., Sergi, D., Maria, R. D., & Lauro, L. D. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3087-3 · Cited by 21
Effects of Transdermal Testosterone Gel or an Aromatase Inhibitor on Prostate Volume in Older Men
Dias, J. P., Melvin, D. L., Shardell, M. D., Ferrucci, L., Chia, C. W., Gharib, M., Egan, J. M., & Basaria, S. S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1111 · Cited by 24
Liu, T.-C., Lin, C.-H., Huang, C., Ivy, J. L., & Kuo, C. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-013-2607-x · Cited by 22
Nuttall, F. Q. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0093 · Cited by 19
Le, B., Chen, H., Zirkin, B. R., & Burnett, A. L. “. (2014) · Andrology · doi:10.1111/j.2047-2927.2014.00225.x · Cited by 18
Alternatives to testosterone replacement: testosterone restoration
McCullough, A. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.143736 · Cited by 18
Effects of Smoking Cessation on Hormonal Levels in Men
HRUŠKOVIČOVÁ, H., DUŠKOVÁ, M., ŠIMŮNKOVÁ, K., HILL, M., POSPÍŠILOVÁ, H., RÁCZ, B., KRÁLÍKOVÁ, E., VONDRA, K., & STÁRKA, L. (2013) · Physiological Research · doi:10.33549/physiolres.932326 · Cited by 17
Testosterone replacement therapy and spermatogenesis in reproductive age men
Naelitz, B. D., Momtazi-Mar, L., Vallabhaneni, S., Cannarella, R., Vij, S. C., Parekh, N. V., Bole, R., & Lundy, S. D. (2025) · Nature Reviews Urology · doi:10.1038/s41585-025-01032-8 · Cited by 26
Erectile Dysfunction: A Review of Comprehensive Treatment Options for Optimal Outcome
Retzler, K. (2019) · Journal of Restorative Medicine · doi:10.14200/jrm.2019.0104 · Cited by 21
Is There Room for SERMs or SARMs as Alternative Therapies for Adult Male Hypogonadism?
Giagulli, V. A., Silvestrini, A., Bruno, C., Triggiani, V., Mordente, A., & Mancini, A. (2020) · International Journal of Endocrinology · doi:10.1155/2020/9649838 · Cited by 14
“did not find any significant difference in ED assessed by the International Index of Erectile Function during anastrozole (1mg/day) therapy in a placebocontrolled study conducted in elderly men [25].”
MethodNovel androgen therapies including selective androgen receptor modulators
Kang, J., Chen, R., Tharakan, T., & Minhas, S. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101686 · Cited by 16
Langham, S., Maggi, M., Schulman, C., Quinton, R., & Uhl-Hochgräber, K. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01015.x · Cited by 15
Rohle, D., Wilborn, C., Taylor, L. W., Mulligan, C., Kreider, R. B., & Willoughby, D. S. (2007) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-4-13 · Cited by 13
The Steroid Spectrum During and After Quitting Smoking
JANDIKOVA, H., DUSKOVA, M., SIMUNKOVA, K., RACZ, B., HILL, M., KRALIKOVA, E., VONDRA, K., & STARKA, L. (2015) · Physiological Research · doi:10.33549/physiolres.933068 · Cited by 11
Mechlin, C. W., Frankel, J., & McCullough, A. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12320 · Cited by 11
Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy
Davidiuk, A. J., & Broderick, G. A. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.09.02 · Cited by 16
Estrogen, testosterone, and sequential movement in men.
Siegel, J. A., Young, L., Neiss, M. B., Samuels, M. H., Roselli, C. E., & Janowsky, J. S. (2008) · Behavioral Neuroscience · doi:10.1037/a0013045 · Cited by 11
Pitts, W. R. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.06896.x · Cited by 10
Investigating the basis of sexual dysfunction during late-onset hypogonadism
Tharakan, T., Miah, S., Jayasena, C. N., & Minhas, S. (2019) · F1000Research · doi:10.12688/f1000research.16561.1 · Cited by 10
Emerging drugs for hypogonadism
Edelstein, D. L., Dobs, A. S., & Basaria, S. S. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.4.685 · Cited by 9
Effect of cigarette smoking on serum testosterone level among male smokers: a cross-sectional study
Salam, M. A. A. E., Zaki, S., Mousa, M. S., & Motawi, A. T. (2021) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.4103/ejcdt.ejcdt_61_20 · Cited by 10
Testosterone, estradiol and aromatase inhibitor therapy in elderly men
Leder, B. Z. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.018 · Cited by 8
Self-citationSigalos, J. T., Pastuszak, A. W., & Khera, M. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.10.011 · Cited by 12
Endocrine Care of Transgender Adults
Fishman, S. L., Paliou, M., Poretsky, L., & Hembree, W. C. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-05683-4_8 · Cited by 11
Michihara, S., Shin, N., Watanabe, S., Morimoto, Y., Okubo, T., & Norimoto, H. (2013) · The Aging Male · doi:10.3109/13685538.2012.755507 · Cited by 10
Management of Hypogonadism in Cardiovascular Patients
Tanna, M. S., Schwartzbard, A. Z., Berger, J. S., Underberg, J. A., Gianos, E., & WEINTRAUB, H. S. (2016) · Urologic Clinics of North America · doi:10.1016/j.ucl.2016.01.011 · Cited by 7
Testosterone and male rejuvenation
Helo, S., Thomas, P., & Tadros, N. N. (2019) · Panminerva Medica · doi:10.23736/s0031-0808.18.03513-9 · Cited by 5
A phase plane graph based model of the ovulatory cycle lacking the "positive feedback" phenomenon
Kurbel, S. (2012) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-9-35 · Cited by 5
Age-Related Changes in the Testicular Morphophysiology of the Cane Rat (Thryonomys swinderianus)
Omirinde, J. O., Olukole, S. G., & Oke, B. O. (2021) · Journal of Microscopy and Ultrastructure · doi:10.4103/jmau.jmau_84_20 · Cited by 8
Rezaee, M. S., Farzinpour, A., Farshad, A., & Hatfaludi, T. (2022) · Italian Journal of Animal Science · doi:10.1080/1828051x.2021.2007801 · Cited by 6
Martinez-Arguelles, D. B., Nedow, J., Gukasyan, H. J., & Papadopoulos, V. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1003017 · Cited by 7
Alternative Treatment Modalities for the Hypogonadal Patient
Trost, L. W., & Khera, M. (2014) · Current Urology Reports · doi:10.1007/s11934-014-0417-2 · Cited by 7
Metadata
- Authors
- Leder, B. Z., Rohrer, J. L., Rubin, S. D., Gallo, J., & Longcope, C.
- Affiliations
- Massachusetts General Hospital (US)
- AstraZeneca (United States) (US)
- AstraZeneca Pharmaceuticals (S.D.R., J.G.), Wilmington, Delaware 19850
- University of Massachusetts Chan Medical School (US)
- ORCID
- Leder, Benjamin Z.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-03-01
- Volume
- 89
- Issue
- 3
- Pages
- 1174-1180
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2117332496
- Semantic Scholar
- aedcb017eb7fc20eca8962b9ec633cc90042cd64
- Cited by
- 149
- References
- 68
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 5 · 2020: 7 · 2019: 8 · 2018: 5 · 2017: 3 · 2016: 10 · 2015: 8 · 2014: 7 · 2013: 6 · 2012: 5
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (K23 RR 16310, K23RR016310)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Keywords
- anastrozole, aromatase inhibitors, older men, androgen deficiency, testosterone replacement therapy, estradiol suppression, luteinizing hormone, sexual function, erectile function, benign prostatic hyperplasia, quality of life, adverse effects, drug safety, age-related testosterone decline, prostate-specific antigen, LH/FSH ratio
- MeSH terms
- Anastrozole, Aged, Aging, Enzyme Inhibitors, Estrogens, Humans, Hypogonadism, Male, Middle Aged, Nitriles, Quality of Life, Testosterone, Triazoles, Treatment Outcome, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.